Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Trial of Endostar Combined With CHOPT for T Cell Lymphoma

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2011 by Tianjin Medical University Cancer Institute and Hospital.
Recruitment status was  Active, not recruiting
Simcere Pharmaceutical Co., Ltd
Information provided by (Responsible Party):
Tianjin Medical University Cancer Institute and Hospital Identifier:
First received: July 11, 2011
Last updated: November 2, 2015
Last verified: September 2011
No Study Results Posted on for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2015
  Estimated Primary Completion Date: November 2015 (Final data collection date for primary outcome measure)